Clinical trials
Mesothelioma, Malignant trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Active, not recruiting | 5 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Health Network, Toronto | 4 |
| National Cancer Institute (NCI) | 3 |
| AGC Biologics S.p.A. | 1 |
| AstraZeneca | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Ferring Ventures Limited | 1 |
| MedImmune LLC | 1 |
| Medicenna Therapeutics, Inc. | 1 |
| Morphotek | 1 |
| NCIC Clinical Trials Group | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mesothelioma, Malignant | 19 |
| Mesothelioma | 4 |
| Ovarian Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Lung Neoplasms | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Uterine Cervical Neoplasms | 2 |
| Adenocarcinoma, Follicular | 1 |
| Adrenocortical Carcinoma | 1 |
| Astrocytoma | 1 |
Trials
Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.